Data / Drug companies / V2 Pharma, LLC
V2 Pharma, LLC: 24 products in the FDA NDC directory, labeler code 72835
V2 Pharma, LLC (labeler code 72835) lists 24 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 15 prescription drugs, 9 over the counter drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on October 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72835
- Products in commercial distribution
- 24
- Packages
- 23
- Finished drugs by generic name
- 10
- Prescription products
- 15
- Over the counter products
- 9
- Flagged as original packager
- 22 of 22 products that carry the flag
- Started marketing in the last 12 months
- 9
- Earliest marketing start
- June 3, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 15 | 62.5% |
| Over the counter monograph drugs | 8 | 33.3% |
| Generic drugs (ANDA) | 1 | 4.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 15 | 62.5% |
| Over the counter drugs | 9 | 37.5% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Lidocaine | 4 | 216 |
| Lidocaine 4% | 4 | 45 |
| Diclofenac sodium and menthol, methyl salicylate | 4 | 2 |
| Lidocaine hydrochloride | 3 | 134 |
| Calcipotriene cream, 0.005% and transparent dressing | 2 | 1 |
| Capsaicin | 1 | 66 |
| Leflunomide and diclofenac sodium gel | 1 | 1 |
| Diclofenac sodium and menthol / camphor gel | 1 | 1 |
| Triamcinolone acetonide cream 0.1%, transparent dressing | 1 | 1 |
| Methyl salicylate, menthol | 1 | 15 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 13 | 54.2% |
| Cream | 3 | 12.5% |
| Capsule | 2 | 8.3% |
| Liquid | 2 | 8.3% |
| Patch | 2 | 8.3% |
| Tape | 1 | 4.2% |
| Gel | 1 | 4.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 7 |
| Antiarrhythmic | 7 |
| Vitamin C | 2 |
| Vitamin D | 2 |
| Photoenhancer | 1 |
| Vitamin B6 Analog | 1 |
| Blood Coagulation Factor | 1 |
| Phosphate Binder | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lidocaine 4% Patch | 72835-400 | Patch | Over the counter monograph drugs | October 28, 2026 |
| Lidoflect | 72835-404 | Patch | Over the counter monograph drugs | October 20, 2026 |
| Lidovyx | 72835-447 | Gel | Over the counter monograph drugs | June 25, 2026 |
| Lidozall Pro | 72835-445 | Cream | Over the counter monograph drugs | June 16, 2026 |
| Dermavyx | 72835-777 | Kit | Other unapproved drugs | May 5, 2026 |
| Orthrexo | 72835-333 | Kit | Other unapproved drugs | April 2, 2026 |
| LidoTape | 72835-040 | Tape | Over the counter monograph drugs | April 1, 2026 |
| Relivyx Plus | 72835-555 | Kit | Other unapproved drugs | March 31, 2026 |
| Cipotrex | 72835-922 | Kit | Other unapproved drugs | March 27, 2026 |
| Crysalo | 72835-511 | Liquid | Other unapproved drugs | August 21, 2025 |
| Orthaphen | 72835-222 | Kit | Other unapproved drugs | July 28, 2025 |
| Syntherma Plus | 72835-105 | Kit | Other unapproved drugs | July 1, 2025 |
| Matervia | 72835-660 | Capsule | Other unapproved drugs | June 11, 2025 |
| Cobalefol | 72835-550 | Capsule | Other unapproved drugs | May 16, 2025 |
| Zestama | 72835-175 | Liquid | Over the counter monograph drugs | April 1, 2025 |
| Lidozall Plus | 72835-114 | Cream | Over the counter monograph drugs | February 11, 2025 |
| Lidozall | 72835-004 | Cream | Over the counter monograph drugs | November 21, 2024 |
| Inflatherm | 72835-701 | Kit | Other unapproved drugs | August 13, 2024 |
| Trionex | 72835-902 | Kit | Other unapproved drugs | January 13, 2023 |
| Lefluniclo | 72835-602 | Kit | Other unapproved drugs | January 11, 2023 |
| Elemar Patch | 72835-502 | Kit | Other unapproved drugs | February 22, 2022 |
| Fenovar | 72835-202 | Kit | Other unapproved drugs | January 21, 2022 |
| LMR Plus | 72835-501 | Kit | Other unapproved drugs | June 3, 2019 |
| Varophen | 72835-201 | Kit | Generic drugs (ANDA) | June 3, 2019 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.